4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 02-2021 | 12-2020 | 11-2020 | 08-2020 | |
| Operating Expenses | 0 | 35,133 | 35,133 | 197 | 201 |
| Operating Income | N/A | -34,443 | -34,443 | -197 | -201 |
| Other Income | 0 | 4,449 | 4,455 | 0 | 1 |
| Pre-tax Income | 0 | -29,994 | -29,988 | -196 | -200 |
| Net Income Continuous | N/A | -29,981 | -29,975 | -196 | -200 |
| Net Income | $N/A | $-29,981 | $-29,975 | $-196 | $-200 |
| EPS Basic Total Ops | N/A | N/A | -1.88 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | N/A | N/A | -1.88 | -0.10 | -0.10 |
| EPS Diluted Total Ops | N/A | N/A | -1.88 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | N/A | N/A | -1.88 | -0.10 | -0.10 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.09 | N/A | N/A |
| EBITDA(a) | $N/A | $-35,133 | $-35,133 | $-197 | $-201 |